Abstract:Background: Medical plants confer various benefits to human health and their bioconversion through microbial fermentation can increase efficacy, reduce toxicity, conserve resources and produce new chemical components. In this study, the cholesterol-lowering monacolin K genes and content produced by Monascus species were identified. The high-yield monacolin K strain further fermented with various medicinal plants. The antioxidant and anti-inflammatory activities, red pigment and monacolin K content, total phenolic content, and metabolites in the fermented products were analyzed. Results: Monacolin K was detected in Monascus pilosus (BCRC 38072), and Monascus ruber (BCRC 31533, 31523, 31534, 31535, and 33323). It responded to the highly homologous mokA and mokE genes encoding polyketide synthase and dehydrogenase. The high-yield monacolin K strain, M. ruber BCRC 31535, was used for fermentation with various medicinal plants. A positive relationship between the antioxidant capacity and total phenol content of the fermented products was observed after 60 days of fermentation, and both declined after 120 days of fermentation. By contrast, red pigment and monacolin K accumulated over time during fermentation, and the highest monacolin K content was observed in the fermentation of Glycyrrhiza uralensis, as confirmed by RT-qPCR. Moreover, Monascus-fermented medicinal plants including Paeonia lactiflora, Alpinia oxyphylla, G. uralensis, and rice were not cytotoxic. Only the product of Monascus-fermented G. uralensis significantly exhibited the anti-inflammatory capacity in a dose-dependent manner in lipopolysaccharide-induced Raw264.7 cells. The metabolites of G. uralensis with and without fermentation (60 days) were compared by LC/MS. 2,3-Dihydroxybenzoic acid, 3,4-dihydroxyphenylglycol, and 3-amino-4-hydroxybenzoate were considered to enhance the antioxidant and anti-inflammatory ability. Conclusions: Given that highly homologous monacolin K and citrinin genes can be observed in Monascus spp., monacolin K produced by Monascus species without citrinin genes can be detected through the complementary methods of PCR and HPLC. In addition, the optimal fermentation time was important to the acquisition of antioxidants, red pigment and monacolin K. These bioactive substances were significantly affected by medicinal plants over fermentation time. Consequently, Monascus-fermented G. uralensis had a broad spectrum of biological activities.

Research Progress of Monascus Purpureus Single Drug and Compound Preparation in the Treatment of Hyperlipi-demia

Retrospective study of monascus purpureus compound preparation in treating phlegm turbidity and blood stasis type primary dyslipidemia

Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine

Modulation of the Gut Microbiota and Liver Transcriptome by Red Yeast Rice and Monascus Pigment Fermented by Purple Monascus SHM1105 in Rats Fed with a High-Fat Diet

Comprehensive Chemical Profiling of Monascus-Fermented Rice Product and Screening of Lipid-Lowering Compounds Other Than Monacolins

Investigations into Chemical Components from Monascus purpureus with Photoprotective and Anti-Melanogenic Activities

Progress in the Studies on Effective Components of Chinese Medicine in the Treatment of Hyperlipidemia

Identification of the high-yield monacolin K strain from Monascus spp. and its submerged fermentation using different medicinal plants

Diversifying of Chemical Structure of Native Monascus Pigments

Non-anti-hyperlipemic Effects of Monascus-fermented Rice and Its Mechanism: Recent Advances

Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine

Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects

Effective enhancement of the ability of Monascus pilosus to produce lipid-lowering compound Monacolin K via perturbation of metabolic flux and histone acetylation modification

Monascus Red Pigment Liposomes: Microstructural Characteristics, Stability, and Anticancer Activity

Synthetic biology for Monascus: From strain breeding to industrial production

Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective

Recent Research Progress in Natural Bioactive Constituents against Lipid Metabolic Diseases

Strategies to enhance the production efficiency of Monascus pigments and control citrinin contamination

Antibacterial effects of monascu and its application

Monascus ruber fermented Panax ginseng ameliorates lipid metabolism disorders and modulate gut microbiota in rats fed a high-fat diet

Production of red yeast rice rich in monacolin K by variable temperature solid fermentation of Monascus purpureus